PathoGenetix Seals $7.5M Series B
Woburn, Mass.-based PathoGenetix Inc. has raised $7.5 million in a second closing of its Series B financing round. The company announced a $4 million first closing of the round in August. The latest installment brings the Series B total to $11.5 million. Investors include Ascension Health Ventures, Excel Venture Management, CB Health Ventures, and HealthCare Ventures. PathoGenetix develops genome sequence scanning technology.
1 November 2011•3 mins read
